Moderna Inc. Stock Slips 5.7%, Underperforms Peers

Dow Jones05:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. slid 5.7% to $49.83 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 22,516.69 and Dow Jones Industrial Average falling 0.8% to 48,501.27.

This was the stock's second consecutive day of losses.

Moderna Inc. closed 9.7% below its 52-week high of $55.20, which the company achieved on January 22nd.

The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.7% to $246.75, Pfizer Inc. fell 2.5% to $26.58, and Gilead Sciences Inc. fell 1.47% to $147.83.

Trading volume totaled 8.2 million, compared to the 50-day average of 12.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 03, 2026 16:34 ET (21:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616716374?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 05:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616716374","market":"hk","top_or_hot":-1,"title":"Moderna Inc. Stock Slips 5.7%, Underperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. slid 5.7% to $49.83 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 22,516.69 and Dow Jones Industrial Average falling 0.8% to 48,501.27. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Moderna Inc. closed 9.7% below its 52-week high of $55.20, which the company achieved on January 22nd. \n</p>\n<p>\n     The stock underperformed when compared to some of its peers, as Johnson &amp; Johnson fell 0.7% to $246.75, Pfizer Inc. fell 2.5% to $26.58, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. fell 1.47% to $147.83. \n</p>\n<p>\n     Trading volume totaled 8.2 million, compared to the 50-day average of 12.1 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2026 16:34 ET (21:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Inc. Stock Slips 5.7%, Underperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Inc. Stock Slips 5.7%, Underperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-04 05:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. slid 5.7% to $49.83 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 22,516.69 and Dow Jones Industrial Average falling 0.8% to 48,501.27. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Moderna Inc. closed 9.7% below its 52-week high of $55.20, which the company achieved on January 22nd. \n</p>\n<p>\n     The stock underperformed when compared to some of its peers, as Johnson &amp; Johnson fell 0.7% to $246.75, Pfizer Inc. fell 2.5% to $26.58, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. fell 1.47% to $147.83. \n</p>\n<p>\n     Trading volume totaled 8.2 million, compared to the 50-day average of 12.1 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2026 16:34 ET (21:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2616716374","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616716374","pubTimestamp":1772573640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.7% to $49.83 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 22,516.69 and Dow Jones Industrial Average falling 0.8% to 48,501.27.This was the stock's second consecutive day of losses.Moderna Inc. closed 9.7% below its 52-week high of $55.20, which the company achieved on January 22nd.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.7% to $246.75, Pfizer Inc. fell 2.5% to $26.58, and Gilead Sciences Inc. fell 1.47% to $147.83.Trading volume totaled 8.2 million, compared to the 50-day average of 12.1 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","MRNY":"MRNA期权收益策略ETF-YieldMax","BK4532":"文艺复兴科技持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4551":"寇图资本持仓","BK4501":"段永平概念","BK4534":"瑞士信贷持仓","MRNX":"Defiance Daily Target 2X Long MRNA ETF","BK4588":"碎股","MRNA":"Moderna, Inc.","BK4568":"美国抗疫概念","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓"},"translate_title":"Moderna Inc.股价下跌5.7%，表现逊于同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9,"MRNX":0.6,"MRNY":0.6},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Moderna Inc. slid 5.7% to $49.83 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 22,516.69 and Dow Jones Industrial Average falling 0.8% to 48,501.27. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Moderna Inc. closed 9.7% below its 52-week high of $55.20, which the company achieved on January 22nd. \n\n\n     The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.7% to $246.75, Pfizer Inc. fell 2.5% to $26.58, and Gilead Sciences Inc. fell 1.47% to $147.83. \n\n\n     Trading volume totaled 8.2 million, compared to the 50-day average of 12.1 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2026 16:34 ET (21:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616716374","isCrawlerRequest":true}